ESLAW Annual CFF
$12.79 M
+$12.79 M+100.00%
30 June 2024
Summary:
As of February 5, 2025, ESLAW annual cash flow from financing activities is $12.79 million, with the most recent change of +$12.79 million (+100.00%) on June 30, 2024. During the last 3 years, it has risen by +$12.12 million (+1807.21%).ESLAW Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW Quarterly CFF
-$150.47 K
+$119.88 K+44.34%
30 September 2024
Summary:
As of February 5, 2025, ESLAW quarterly cash flow from financing activities is -$150.47 thousand, with the most recent change of +$119.88 thousand (+44.34%) on September 30, 2024. Over the past year, it has increased by +$6.75 million (+97.82%).ESLAW Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW TTM CFF
-$7.40 M
-$20.20 M-157.86%
30 September 2024
Summary:
As of February 5, 2025, ESLAW TTM cash flow from financing activities is -$7.40 million, with the most recent change of -$20.20 million (-157.86%) on September 30, 2024. Over the past year, it has dropped by -$20.55 million (-156.30%).ESLAW TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLAW Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | +97.8% | -156.3% |
| 3 y3 years | +1807.2% | +97.8% | -156.3% |
| 5 y5 years | +1807.2% | +97.8% | -156.3% |
ESLAW Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -100.8% | -136.9% |
Estrella Immunopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$150.47 K(-44.3%) | -$7.40 M(-157.9%) |
| June 2024 | $12.79 M | -$270.35 K(+221.5%) | $12.79 M(-2.1%) |
| Mar 2024 | - | -$84.09 K(-98.8%) | $13.06 M(-0.6%) |
| Dec 2023 | - | -$6.90 M(-134.4%) | $13.15 M(-34.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $20.05 M(>+9900.0%) | $20.05 M(>+9900.0%) |
| June 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | - | $0.00 | $0.00 |
| June 2022 | $5.53 M(+724.4%) | - | - |
| June 2021 | $670.82 K | - | - |
FAQ
- What is Estrella Immunopharma annual cash flow from financing activities?
- What is the all time high annual CFF for Estrella Immunopharma?
- What is Estrella Immunopharma annual CFF year-on-year change?
- What is Estrella Immunopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly CFF year-on-year change?
- What is Estrella Immunopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Estrella Immunopharma?
- What is Estrella Immunopharma TTM CFF year-on-year change?
What is Estrella Immunopharma annual cash flow from financing activities?
The current annual CFF of ESLAW is $12.79 M
What is the all time high annual CFF for Estrella Immunopharma?
Estrella Immunopharma all-time high annual cash flow from financing activities is $12.79 M
What is Estrella Immunopharma annual CFF year-on-year change?
Over the past year, ESLAW annual cash flow from financing activities has changed by +$12.79 M (+100.00%)
What is Estrella Immunopharma quarterly cash flow from financing activities?
The current quarterly CFF of ESLAW is -$150.47 K
What is the all time high quarterly CFF for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly cash flow from financing activities is $20.05 M
What is Estrella Immunopharma quarterly CFF year-on-year change?
Over the past year, ESLAW quarterly cash flow from financing activities has changed by +$6.75 M (+97.82%)
What is Estrella Immunopharma TTM cash flow from financing activities?
The current TTM CFF of ESLAW is -$7.40 M
What is the all time high TTM CFF for Estrella Immunopharma?
Estrella Immunopharma all-time high TTM cash flow from financing activities is $20.05 M
What is Estrella Immunopharma TTM CFF year-on-year change?
Over the past year, ESLAW TTM cash flow from financing activities has changed by -$20.55 M (-156.30%)